跳至主要内容
临床试验/NCT03623230
NCT03623230已完成4 期

Concentration-Volume Relationship of Bupivacaine in Femoral Nerve Block Efficiency for Postoperative Analgesia in Primary Total Knee Arthroplasty: A Randomized Controlled Double Blind Clinical Trial

Bozyaka Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 63 人开始时间: 2018年8月10日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
63
试验地点
1
主要终点
Post-operative pain assessed by Numeric Rating Scale (NRS)

研究概览

简要总结

US-guided femoral nerve block is used effectively in post-operative pain management in the surgical treatment of the lower extremity. However, the volume and concentration of the local anesthetic drug to be administered remains controversial. In this prospective, randomized, double-blinded study, patients who underwent unilateral primary total knee arthroplasty and successfully performed spinal anesthesia with standard method and dosage, will be selected for US-guided femoral nerve block after the operation. Patients will be divided into three groups with simple randomization. The First group will be determined as the control group (GCont) and only dressing will be applied to the patients. For second group(G125), 0,125% 20 ml local anesthetic and for the third group (G25), 0,25% 10 ml local anesthetic will be administered to the femoral nerve without changing the drug dose (25 mg bupivacaine). Whether there is a difference between post-op analgesia durations, motor block formation, mobilization time and 90° flexion time between the groups will be investigated.

详细描述

All patients scheduled for total knee arthroplasty will be evaluated before the operation. Eligible patients will be informed about the study and "Numeric Rating Scale" for pain evaluation. Then, patients will be asked for informed consent. After approval from the local research ethics committee, first patient will be recruited for study and patient's group will be determined by dice roll(1,4: GCont - 2,5: G125 - 3,6: G25). Patients who are scheduled for primary total knee arthroplasty under spinal anesthesia with a planned sensory block level between T4 and T7 dermatomes, will be recruited and assigned to a group. After successfully completed surgery, patients will be administered femoral nerve block or only dressing according to the relevant group. Before femoral nerve block is performed, patients will be re-informed about Numeric Rating Scale(NRS) and will be asked to rate their pain at the moment.

  • Control Group(GCont) patients will only be applied sterile dressing for the purpose of blinding the patient and the follow-up physician.
  • 0.125% Bupivacaine Group(G125) patients will be administered femoral block with 20 ml 0.125% Bupivacaine by an experienced anesthesiologist.
  • 0.25% Bupivacaine Group(G25) patients 10ml will be administered femoral block with 0.25% Bupivacaine by an experienced anesthesiologist.

The procedures will be performed in the operating room under both US and nerve stimulator guidance. Patients will be followed-up in post-anesthesia care unit and in the ward for 48 hours. Scheduled and on-demand(Tramadol) medication for analgesia will be ordered and nurses will be informed about the study. Patients' pain scores and ambulation times will be followed-up by another anesthesiologist and on-demand medication will be recorded and monitored from hospital's computer based hospital management program online. Patients will be followed-up for six months after the surgery in order to explore potential long term benefits and complications.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who are scheduled for primary unilateral total knee arthroplasty under spinal anesthesia
  • Patients who has informed consent for study

排除标准

  • Patient's refusal to participate
  • Patients under 18 years of age
  • Patients who are undergoing surgery with an anesthesia technique other than spinal anesthesia for any reason (general anesthesia, laryngeal mask application, etc.)
  • Patients with known local anesthetic allergy
  • Patients with Body mass index > 35
  • Patients diagnosed sepsis and bacteriemia,
  • Skin infection at the injection site,
  • History of coagulopathy or anticoagulant therapy
  • Patients with uncontrolled diabetes ,
  • Uncoordinated patients,
  • Psychological and emotional lability,
  • Surgical intervention longer than 3 hours.
  • Patients with pre-operative limitation of movement

研究组 & 干预措施

G125 Block

Active Comparator

Ultrasound Guided Femoral Nerve Block: 20ml Bupivacaine 0.125% Injectable Solution will be administered for femoral nerve block.

5ml %0,5 Bupivacaine will be diluted with 15ml Saline solution.

干预措施: Ultrasound Guided Femoral Nerve Block (Procedure)

GCont

Sham Comparator

Only dressing will be applied to patients without actually nerve block performed

干预措施: Dressing (Other)

G125 Block

Active Comparator

Ultrasound Guided Femoral Nerve Block: 20ml Bupivacaine 0.125% Injectable Solution will be administered for femoral nerve block.

5ml %0,5 Bupivacaine will be diluted with 15ml Saline solution.

干预措施: Bupivacaine 0.125% Injectable Solution (Drug)

G25 Block

Active Comparator

Ultrasound Guided Femoral Nerve Block: 10ml Bupivacaine 0.25% Injectable Solution will be administered for femoral nerve block.

5ml %0,5 Bupivacaine will be diluted with 5ml Saline solution.

干预措施: Ultrasound Guided Femoral Nerve Block (Procedure)

G25 Block

Active Comparator

Ultrasound Guided Femoral Nerve Block: 10ml Bupivacaine 0.25% Injectable Solution will be administered for femoral nerve block.

5ml %0,5 Bupivacaine will be diluted with 5ml Saline solution.

干预措施: Bupivacaine 0.25% Injectable Solution (Drug)

结局指标

主要结局

Post-operative pain assessed by Numeric Rating Scale (NRS)

时间窗: 48th hour postoperatively

Pain scores will be recorded as reported by the patient according to NRS

次要结局

  • Ambulation Time(72 hours post-operatively)
  • Opioid Consumption(48 hour post-operatively)

研究者

发起方
Bozyaka Training and Research Hospital
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验